ArticleCephalalgia : an international journal of headache2022

Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies.

Hans Christoph Diener et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.